Home / Stocks / VALEANT PHARMACEUTICALS INTL

VALEANT PHARMACEUTICALS INTL

91911K102

2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30

Holding superinvestors

Superinvestor Shares Value Weight Change
Pershing Square Capital Management 19,473,933 $3.868B 25.8% New
ValueAct Capital 19,383,877 $3.85B 21.3% -
Brave Warrior Advisors 5,877,016 $1.167B 35.6% Reduced
Lone Pine Capital 5,569,460 $1.106B 4.7% Reduced
Viking Global Investors 4,058,343 $806.1M 3.2% Reduced
Davis Advisors 1,877,040 $372.8M 1.3% Reduced
Maverick Capital 1,275,861 $253.4M 4.1% Reduced
First Eagle Investment Management 1,191,832 $236.7M 0.6% -
Weitz Investment Management 917,261 $182.2M 4.9% Reduced
Giverny Capital 154,080 $30.6M 6.7% -

By quarter

Quarter Holders Total value
2013-06-30 8 $4.05B
2013-09-30 7 $4.725B
2013-12-31 8 $5.354B
2014-03-31 9 $6.66B
2014-06-30 8 $6.968B
2014-09-30 8 $7.245B
2014-12-31 8 $7.347B
2015-03-31 10 $11.87B
2015-06-30 10 $12.11B
2015-09-30 10 $10.1B
2015-12-31 8 $5.795B
2016-03-31 8 $1.338B
2016-06-30 6 $961.2M
2016-09-30 6 $1.18B
2016-12-31 6 $690.3M
2017-03-31 5 $337.4M
2017-06-30 4 $495.2M
2017-09-30 5 $412.3M
2017-12-31 4 $526.6M
2018-03-31 4 $409.3M
2018-06-30 4 $581.2M